Microbot Medical MBOT EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Microbot Medical’s reported figures.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's EBITDA?
- Microbot Medical (MBOT) reported EBITDA of -$4.31M in Q1 2026.
- How has Microbot Medical's EBITDA changed year-over-year?
- Microbot Medical's EBITDA decreased by 43.3% year-over-year, from -$3.01M to -$4.31M.
- What is the long-term trend for Microbot Medical's EBITDA?
- Over 4 years (2021 to 2025), Microbot Medical's EBITDA has grown at a 6.8% compound annual growth rate (CAGR), from -$11.28M to -$14.7M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.